Alpha proteinase inhibitor (human)

(Prolastin-C)

Alpha proteinase inhibitor (human)

Drug updated on 1/4/2024

Dosage FormInjection (intravenous: 500 mg (10 mL), 100 mg (20 mL), 4000 mg (80 mL))
Drug ClassAlpha proteinase inhibitor (human)
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to severe hereditary deficiency of Alpha1-PI (alpha1-antitripsin deficiency).

Product Monograph / Prescribing Information

Document TitleYearSource
Prolastin-C Liquid (alpha-1 proteinase inhibitor) Prescribing Information.2020Grifols Therapeutics, Research Triangle Park, NC